Genetic Testing for Hereditary Colorectal Cancer

Surgical Oncology Clinics of North America

Volumn 18, Issue 4, 2009, Pages 687-703

  Hampel, Heather ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Colorectal neoplasm; Genetic; Lynch syndrome; Polyposis syndromes; Testing

Indexed keywords

B RAF KINASE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; DNA GLYCOSYLASE MUTY; MISMATCH REPAIR PROTEIN PMS2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN MLH1; SMAD4 PROTEIN;

ADENOMATOUS POLYP; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CANCER SUSCEPTIBILITY; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; EPIGENETICS; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; FAMILY STUDY; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAMARTOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ONCOGENE; PEUTZ JEGHERS SYNDROME; PRACTICE GUIDELINE; PROMOTER REGION; REVIEW; SENSITIVITY AND SPECIFICITY;

COLORECTAL NEOPLASMS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS;

EID: 70349316521     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.08.001     Document Type: Review

References (78)

1. Howe J.R., Roth S., Ringold J.C., et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998) 1086
2. Howe J.R., Bair J.L., Sayed M.G., et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28 (2001) 184
3. Calva-Cerqueira D., Chinnathambi S., Pechman B., et al. The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis. Clin Genet 75 (2009) 79
4. Gallione C.J., Repetto G.M., Legius E., et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363 (2004) 852
5. Hemminki A., Markie D., Tomlinson I., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391 (1998) 184
6. Aretz S., Stienen D., Uhlhaas S., et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 26 (2005) 513
7. Buchet-Poyau K., Mehenni H., Radhakrishna U., et al. Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2. Cytogenet Genome Res 97 (2002) 171
8. Mehenni H., Gehrig C., Nezu J., et al. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet 63 (1998) 1641
9. Olschwang S., Boisson C., and Thomas G. Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 38 (2001) 356
10. Burt R.W., and Jass J. Hyperplastic polyposis. In: Hamilton S.R., and Aaltonen L.A. (Eds). World Health Organisation classification of tumours pathology and genetics (2000), Springer-Verlag, Berlin 135
11. Liaw D., Marsh D.J., Li J., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 (1997) 64
12. Marsh D.J., Dahia P.L., Zheng Z., et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16 (1997) 333
13. Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns 18 (2009) 13
14. Carlson G.J., Nivatvongs S., and Snover D.C. Colorectal polyps in Cowden's disease (multiple hamartoma syndrome). Am J Surg Pathol 8 (1984) 763
15. Chen Y.M., Ott D.J., Wu W.C., et al. Cowden's disease: a case report and literature review. Gastrointest Radiol 12 (1987) 325
16. Marra G., Armelao F., Vecchio F.M., et al. Cowden's disease with extensive gastrointestinal polyposis. J Clin Gastroenterol 18 (1994) 42
17. Nelen M.R., Kremer H., Konings I.B., et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 7 (1999) 267
18. Marsh D.J., Coulon V., Lunetta K.L., et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7 (1998) 507
19. Tsou H.C., Teng D.H., Ping X.L., et al. The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Hum Genet 61 (1997) 1036
20. Zhou X.P., Waite K.A., Pilarski R., et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73 (2003) 404
21. Chibon F., Primois C., Bressieux J.M., et al. Contribution of PTEN large rearrangements in cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach. J Med Genet 45 (2008) 657
22. Groden J., Thliveris A., Samowitz W., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991) 589
23. Nishisho I., Nakamura Y., Miyoshi Y., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253 (1991) 665
24. Friedl W., Caspari R., Sengteller M., et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48 (2001) 515
25. Powell S.M., Petersen G.M., Krush A.J., et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329 (1993) 1982
26. van der Luijt R.B., Khan P.M., Vasen H.F., et al. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum Mutat 9 (1997) 7
27. Aretz S., Stienen D., Uhlhaas S., et al. Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 42 (2005) 185
28. Bunyan D.J., Eccles D.M., Sillibourne J., et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91 (2004) 1155
29. De Rosa M., Scarano M.I., Panariello L., et al. Three submicroscopic deletions at the APC locus and their rapid detection by quantitative-PCR analysis. Eur J Hum Genet 7 (1999) 695
30. Nielsen M., Bik E., Hes F.J., et al. Genotype-phenotype correlations in 19 Dutch cases with APC gene deletions and a literature review. Eur J Hum Genet 15 (2007) 1034
31. Sieber O.M., Lamlum H., Crabtree M.D., et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A 99 (2002) 2954
32. Poulsen ML., and Bisgaard ML. MUTYH associated polyposis (MAP). Curr Genomics 9 (2008) 420
33. Nielsen M., Hes F.J., Nagengast F.M., et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71 (2007) 427
34. Knudsen A.L., Bisgaard M.L., Bulow S., et al. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2 (2003) 43
35. Al-Tassan N., Chmiel N.H., Maynard J., et al. Inherited variants of MYH associated with somatic G:C-> T:A mutations in colorectal tumors. Nat Genet 30 (2002) 227
36. Aretz S., Uhlhaas S., Goergens H., et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119 (2006) 807
37. Enholm S., Hienonen T., Suomalainen A., et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 163 (2003) 827
38. Isidro G., Laranjeira F., Pires A., et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat 24 (2004) 353
39. Sieber O.M., Lipton L., Crabtree M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348 (2003) 791
40. Wang L., Baudhuin L.M., Boardman L.A., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127 (2004) 9
41. Cheadle J.P., and Sampson J.R. MUTYH-associated polyposis-from defect in base excision repair to clinical genetic testing. DNA Repair (Amst) 6 (2007) 274
42. Eliason K., Hendrickson B.C., Judkins T., et al. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet 42 (2005) 95
43. Bouguen G., Manfredi S., Blayau M., et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum 50 (2007) 1612
44. Jaeger E., Webb E., Howarth K., et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 40 (2008) 26
45. Jaeger E.E., Woodford-Richens K.L., Lockett M., et al. An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet 72 (2003) 1261
46. Tomlinson I., Rahman N., Frayling I., et al. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology 116 (1999) 789
47. Cao X., Eu K.W., Kumarasinghe M.P., et al. Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet 43 (2006) e13
48. Hampel H., Frankel W.L., Martin E., et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26 (2008) 5783
49. Hampel H., Frankel W.L., Martin E., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352 (2005) 1851
50. Aaltonen L.A., Peltomaki P., Leach F.S., et al. Clues to the pathogenesis of familial colorectal cancer. Science 260 (1993) 812
51. Aaltonen L.A., Peltomaki P., Mecklin J.P., et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54 (1994) 1645
52. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248
53. Rodriguez-Bigas M., Boland C., Hamilton S., et al. National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89 (1997) 1758
54. Muller W., Burgart L.J., Krause-Paulus R., et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study. Fam Cancer 1 (2001) 87
55. Thibodeau S.N., French A.J., Roche P.C., et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56 (1996) 4836
56. Acharya S., Wilson T., Gradia S., et al. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci U S A 93 (1996) 13629
57. Fishel R. The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Res 61 (2001) 7369
58. Jascur T., and Boland C.R. Structure and function of the components of the human DNA mismatch repair system. Int J Cancer 119 (2006) 2030
59. Kadyrov F.A., Dzantiev L., Constantin N., et al. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126 (2006) 297
60. Harfe B.D., Minesinger B.K., and Jinks-Robertson S. Discrete in vivo roles for the MutL homologs Mlh2p and Mlh3p in the removal of frameshift intermediates in budding yeast. Curr Biol 10 (2000) 145
61. Vasen H., Mecklin J.-P., Khan P., et al. The international collaborative group on hereditary non-polyposis colorectal cancer. Dis Colon Rectum 34 (1991) 424
62. Vasen H., Watson P., Mecklin J.-P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116 (1999) 1453
63. Barnetson R.A., Tenesa A., Farrington S.M., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751
64. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 (2006) 1479
65. Balmana J., Stockwell D.H., Steyerberg E.W., et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296 (2006) 1469
66. Lynch H.T., and de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 348 (2003) 919
67. Palomaki G.E., McClain M.R., Melillo S., et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11 (2009) 42
68. Baudhuin L.M., Burgart L.J., Leontovich O., et al. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer 4 (2005) 255
69. Boland C.R., Koi M., Chang D.K., et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer 7 (2008) 41
70. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 10 (2008) 293
71. Hampel H., Frankel W., Panescu J., et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66 (2006) 7810
72. Senter L., Clendenning M., Sotamaa K., et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135 (2008) 419
73. Chao E.C., Velasquez J.L., Witherspoon M.S., et al. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29 (2008) 852
74. Lindor N.M., Rabe K., Petersen G.M., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293 (2005) 1979
75. Balaguer F., Castellvi-Bel S., Castells A., et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 5 (2007) 379
76. Lubbe S.J., Webb E.L., Chandler I.P., et al. Implications of familial colorectal cancer risk profiles and microsatellite instability status. J Clin Oncol 27 (2009) 2238
77. Nielsen M., Joerink-van de Beld M.C., Jones N., et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology 136 (2009) 471
78. Severin MJ. Genetic susceptibility for specific cancers. Medical liability of the clinician. Cancer 86 (1999) 2564